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Abstract
Post-ischemic reperfusion leads to apoptosis-linked
loss of myocytes in cultured cells and in vivo. We
tested the hypothesis that apoptosis develops without
reperfusion in Langendorff-perfused hearts exposed
to either low-flow ischemia (LFI) or hypoxia (H). Rat
hearts were perfused with aminoacid-enriched Krebs-
Henseleit buffer and exposed for 6 h to LFI (flow=2
ml/min, PO2=500±50mmHg, mean±SD), H (10ml/min,
120±15mmHg), or control conditions (C, 10ml/min,
500±50mmHg). At selected times, DNA-fragmentation
was measured by agarose-gel electrophoresis and in
situ TUNEL assay. After 6 h, the ratio (TUNEL-positi-
ve)/(total nuclei) was 0.620±0.027, 0.615±0.005,
0.404±0.021 in LFI, H and C, respectively. The ratio
was 0.813±0.021 in hearts exposed to 90 min global
no-flow ischemia and reperfused (5 h). To assess the
role of membrane-diffusible factors, separate
experiments were performed recirculating the medium
and exposing hearts to LFI or H as above. The degree
of apoptosis was the same in both the recirculating
and non-recirculating modes. Thus, apoptosis
develops by similar extents and in a time-dependent
fashion in crystalloid-perfused rat hearts during LFI
or H at the same oxygen shortage (flow•PO2), even
without the reperfusion.
Introduction
There is a raising interest for apoptosis in
cardiovascular pathophysiology. Cardiac myocytes have
not definitely lost their capacity to regenerate by mitosis,
yet they can not compensate irreversible injury with tissue
regeneration as other organs can do. Thus, although it is
uncertain if beneficial [1], apoptosis plays an important
role in cardiac disease [2]. At present, the oxidative stress
associated to the reperfusion after ischemia is perceived
to be the main signal triggering apoptosis in isolated or
in vivo organs [3-10]. Nevertheless, there is some
evidence that in isolated cardiomyocytes ischemia or
hypoxia alone, without reperfusion, can trigger apoptosis
[11-14]. However, there is no uncontroversial analogue
in in vivo or ex-vivo situations. Mouse hearts develop
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apoptosis after 4 h coronary artery ligation in the
correspondence of hypoxic regions, but independently
of p53 [15]. Rat hearts subjected to 2.25 h coronary artery
occlusion display apoptosis, but in the correspondence
of the inflammatory response caused by neutrophils
accumulation [16]. In isolated rat hearts, the translocation
of phosphatidylethanolamine and phosphatidylserine, an
early sign of apoptosis, develops since ischemia, but the
classical signs of apoptosis are seen only after reperfusion
[17]. Therefore, it is not yet clear if ischemia or hypoxia
alone elicit apoptosis independently of the oxidative
stress.
In this study, we test the hypothesis that apoptosis
develops in Langendorff-perfused hearts exposed to
either sustained low-flow ischemia (LFI) or hypoxia (H)
before reperfusion or reoxygenation. Tissue hypoxia (low
supply of O2) is a component of ischemia (low supply of
blood), but several of the mechanisms underlying the
response to hypoxia and ischemia are different. In
hypoxic cardiac myocytes, apoptosis is mediated by the
decreased intracellular pH resulting from uncoupled
oxidative phosphorylation and intracellular lactate
release [14]. In embryonic stem cells, apoptosis is
stimulated by mechanisms independent of hypoxia-
inducible factor-1α [18]. The transcription of the gene
encoding Nip3, a pro-apoptotic member of the Bcl-2
family of cell death receptors, is increased in hypoxic
cells [19]. Therefore, as hypoxia and ischemia share some
common features, it may become important to
differentiate the effects led by the two stresses, when
applied for the same duration and at comparable degree
of severity. We will show that apoptosis develops by
similar extents and in a time-dependent fashion in
crystalloid-perfused rat hearts during LFI or H at the same
oxygen shortage (flow•PO2) without the need of
reperfusion.
Materials and Methods
Heart perfusion
Hearts were isolated and perfused by the Langendorff
technique as previously described [20]. Briefly, ad libitum fed,
male Sprague Dowley rats (250-280 g) were anesthetized with
sodium thiopental (10 mg/100 g b.w.) plus heparin (500 IU/100 g
b.w.). Excised hearts were mounted on the perfusion system kept
at 37°C (ischemia time 15-30 s). The medium (Krebs-Henseleit
buffer with 2 mM free Ca++, 11 mM glucose, 10 mM HEPES,
pH=7.40±0.02 at 37°C) was supplemented with aminoacids (3.5
mL/L Freamine III 8.5%, Clintec Nutrition Clinique, d’Amilly-
Montargis, France) and oxygenated by bubbling with either 100%
or 21% O
2
. A roller pump (Gilson Minipuls 3, France) delivered
the medium to a 8 µm pore size filter (Nucleopore Corp.,
Pleasanton, CA), a pre-heater and the aortic cannula. A pressure
transducer (Harvard Apparatus model 52-9966, Natick, MA)
between the pump and the aortic cannula provided the coronary
perfusion pressure. The PO
2
 was measured by an O
2
 electrode
(Yellow Spring Instruments Inc, Yellow Spring, OH).
Study design
Hearts were stabilized for 30 min at coronary flow=10 ml/
min with 100% O
2 
medium and were subdivided into four groups.
Control hearts (C, n=3) were perfused for 6 h under the same
conditions of the stabilization. Low-flow ischemia (LFI, n=6) was
induced for 6h by decreasing the pump rate to 2 ml/min. Hypoxia
(H, n=6) was induced for 6h by switching from the oxygenated
(100% O
2
) to the aerated (21% O
2
) perfusion solution. Ischemia-
reperfusion (I/R, n=3) hearts were exposed to global no-flow
ischemia (90 min) by switching off the pump, and reperfused for
5 h under the same conditions of the stabilization.
In another set of experiments, the medium was recirculated
by redirecting the venous outflow into the reservoir (total volu-
me=800 mL). Hearts were stabilized and assigned to the C, LFI,
or H groups (n=4 each) as above.
Biopsies
At selected times, samples were taken for apoptosis
detection. Without switching off the pump, the heart apex was
resected at about 6 mm from the apex, and dropped into liquid
N
2
. The specimen, cut into 0.2-0.3 g fragments, was transferred
without thawing into sterile tubes and kept at -80°C until use.
The remaining part of the heart, still on the perfusion apparatus,
was injected through the aorta with 4% formalin (2 ml). Then, a
circular 2-mm section perpendicular to the heart axis was done.
The section was stored overnight in 4% formalin at ice tempera-
ture, and kept under 15% v/v sucrose at that temperature until
use. To prevent false positives from long times in formalin [21],
we limited formalin fixing to 12-16 h.
DNA extraction and agarose gel electrophoresis of DNA
fragments
Myocardial tissue (about 100 mg) was minced, washed
several times with cold saline and centrifuged, and the pellet
recovered. Each pellet was mixed with 1 mL lysis buffer (7 M
urea, 0.3 M NaCl, 10 mM Tris, pH 7.5), added with 1 mL 10%
SDS and 100 µg/mL proteinase K (Ambion-CelBio, Pero, Italy).
After incubation (2 h, 55°C), an equal volume of phenol saturated
with 1 M Tris at pH 8.0, chloroform and isoamyl alcohol (25:24:1)
was added. The suspension was stirred at room temperature and
centrifuged at 5000 g for 30 min. The aqueous phase was extracted
again with chloroform and isoamyl alcohol (24:1 v/v). DNA was
precipitated by adding 0.3 M NaCl and two volumes of 99.8%
ethanol, collected by centrifugation at 5000 g for 30 min, and
washed in 70% ethanol. The DNA solution was air-dried, re-
suspended in 10 mM Tris, 1 mM EDTA and treated with 100 µg/
mL pancreatic RNase (Fluka Chemie, AG, Switzerland) for 1 h
at 37°C. DNA concentration was measured by spectrophotometry
at λ=260 nm assuming ε=0.02 mL/µg, and subjected to
electrophoresis on 1.2-1.5% agarose gel in 89 mM Tris, 89 mM
boric acid, 2 mM EDTA buffer. Ten µg of DNA was loaded
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together with 1µL of dye (0.25% w/v xilenol, 30% w/v glycerol)
and stained with 0.5 µg/mL ethidium bromide. The gel was
photographed under UV light. A standard constituted by a 100
bp DNA ladder (Amersham Pharmacia Biotech, Little Chalfont,
UK) was used as size marker.
In-situ detection of DNA fragmentation
We used the in situ cell death detection kit Terminal-
deoxynucleotidyl-Transferase (TdT) mediated dUTP Nick End-
Labeling (TUNEL-POD kit, Roche Diagnostics, Switzerland).
Formalin-fixed specimens were embedded in Optimum Cutting
Temperature Compound (Bio Optica, Milan, Italy) and kept under
freezing plate for solidification. Two 5 µm-thick cryosections were
obtained from each specimen (Cryostate CM 1510, Leica,
Germany). Sections were washed with PBS (2.7 mM KCl, 137
mM NaCl, 4.3 mM Na
2
HPO
4
, 1.4 mM KH
2
PO
4
), and incubated
sequentially with 20 µg/ml proteinase K (Clontec Laboratories,
Palo Alto, CA, USA) in 10 mM Tris at pH 8.0 (30 min at room
temperature), 3% H
2
O
2
 in methanol to inhibit endogenous
peroxidase (5 min at room temperature), 0.1% Triton X-100 in
3.4 mM Na citrate for permeabilization (2 min at 4°C), TUNEL
reaction mixture (Roche Label solution and TdT) (60 min at 37°C,
in a humidified chamber). Positive controls were obtained by
incubating sections with 0.9 mg/mL DNaseI (Roche Diagnostics,
Switzerland) diluted in 1mM MgSO
4
 in PBS (20 min at 37°C)
before addition of TUNEL reaction mixture. Peroxidase was
revealed by 3,3’-diaminobenzidine (Histo Mark Black Peroxidase
System, TPL, MD, USA). After staining, sections were
counterstained with Meyer hematoxylin (Fluka Chemie,
Switzerland), dehydrated through crescent alcoholic scale (80%
and 96% ethanol; Fluka Chemie, Switzerland) and immersed 4
times in xylene (Fluka Chemie, Switzerland) for 5 min each. Ne-
gative controls were obtained by incubating sections with label
solution without TdT.
Images
Both TUNEL- and hematoxylin-eosin-stained sections were
analyzed using a light microscope (Zeiss Axiolab, Germany) at
40x magnification. The images obtained using two consecutive
sections treated with the two staining procedures were first
superimposed to assure that stained nuclei belong to cardiac
myocytes. Sixteen images were randomly acquired per each section
using a CCD Color Camera C4200 (Hamamatsu, Japan). Images
were transferred to a PC using Image Grabber 24 (Neotech,
Eastleight, England). Stored images were analyzed with Adobe
PhotoShop (Adobe Systems, San Jose, CA, USA) and adjusted
using the autolevel function. The degree of apoptosis, or apoptotic
index, was assumed proportional to the ratio (number of TUNEL-
positive) / (number of TUNEL-positive + number of hematoxylin-
stained nuclei).
Statistics
Data are expressed as mean±SD. The significance level was
P=0.05 (two-tailed). To detect significant differences among the
three groups considered, we first performed one-way ANOVA
test. If significant, the differences between selected pairs of data
were tested using the Fischer comparison procedure (StatView,
Abacus Concepts, Berkeley, CA).
Results
Low-flow ischemia and hypoxia
Table 1 shows arterial PO
2
 and coronary flow under
the various experimental conditions. The O
2
 supply was
calculated as flow•arterial PO
2
•O
2
 solubility coefficient
in water (1.4•10-6 moles/l [22]). During LFI and H, the
O
2
 supply was 20% of control. There was no significant
difference in O
2
 supply between LFI and H.
In control hearts, the heart rate did not change
appreciably during 6 h perfusion (Figure 1). Either LFI
or H acutely decreased heart rate, yet hearts kept
contracting for the whole duration of LFI or H. In H
hearts, heart rate was intermediate between LFI and C.
Hearts exposed to I/R displayed progressive deterioration
during the reperfusion.
In pump-perfused hearts, the coronary perfusion
pressure is an index of vascular vasoconstriction (Figu-
re 1). In control hearts, the coronary perfusion pressure
increased slightly, but stabilized after 1 h. In H hearts,
the pressure was higher than in C. In LFI heart, the
pressure decreased proportionally to the lower flow rate.
In both LFI and H, however, the perfusion pressure was
maintained for the whole duration of LFI or H. In I/R
hearts, however, steadily increasing perfusion pressure
indicated performance deterioration.
Apoptosis in ischemic and hypoxic hearts
Apoptosis is characterized by cleavage of genomic
DNA into fragments of 180 bp or multiple, which can be
detected as DNA ladder by gel electrophoresis. To detect
Table 1. Arterial PO
2
, coronary flow
and O
2
 supply (PO
2
 • coronary flow •
O
2
 solubility coefficient) in the groups
under study (mean±SD). The
assumed value for the O
2
 solubility
coefficient was 1.4•10-6 M/mmHg. *,
significant (P<0.05) difference from
control.
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Fig. 1. Myocardial dynamics
in the various groups of hearts
examined in this study (n=2-
4/group). The left and right
panels describe hearts
perfused in the open and
closed circuit, without and
with medium recirculation,
respectively. The S.D. (not
shown for clarity) averaged
±10%.
DNA laddering, high molecular weight DNA was
extracted from frozen cardiac tissue at selected times
during the experiments. However, in hearts perfused for
6 h under control, LFI or H conditions, DNA
fragmentation was barely visible (Figure 2).
In situ detection of DNA fragments by the TUNEL
assay yielded the results shown in Figure 3. This method
is based on the new 3’-OH DNA ends generated by DNA
fragmentation. In contrast, normal nuclei, with relatively
low number of DNA 3’-OH ends, were not stained. The
images obtained from two consecutive sections treated
with the two staining procedures (TUNEL- and
hematoxylin-eosin) were superimposed and analyzed to
obtain the apoptotic index. This value increased almost
linearly with time in hearts exposed to either low-flow
ischemia or hypoxia. In contrast, it remained essentially
constant in control hearts (Figure 4). Hearts exposed to
ischemia-reperfusion displayed a higher apoptotic index
than LFI and H hearts (P<0.05).
Medium recirculation
In separate experiments, we aimed at assessing
whether substances released from ischemic or hypoxic
hearts affect the degree of apoptosis. Recirculating the
medium could address this question at the expense of
greater function deterioration, as evident from faster
decrease in heart rate and increase in coronary perfusion
pressure (Figure 1). Nevertheless, the apoptotic index
was unchanged with respect to data obtained without
recirculation. The recirculating setup, although finally
leading to heart arrest, typically for t>9 h (not shown),
allowed to monitor H+ release. The medium pH was
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Fig. 2. Agarose gel electrophoresis of myocardial DNA. All lanes
were loaded with 10 µg DNA together with 1µL of dye and stained
with 0.5 µg/mL ethidium bromide. The gel was photographed
under UV light. A standard constituted by a 100 bp DNA ladder
(Amersham Pharmacia Biotech, Little Chalfont, UK) was used
as size marker. Lanes are as follows (from left to right): hearts
exposed for 6 h to low-flow ischemia (A), hypoxia (B), control
conditions (C), standard fragments (C) constituted by a 100 bp
DNA ladder (Amersham Pharmacia Biotech, Little Chalfont, UK),
with arrowhead indicating 100 bp.
Fig. 3. Staining of myocardial sections by in situ TUNEL assay
in control hearts (A), hearts exposed to 6 h low-flow ischemia
(B), and hearts exposed for 6 h to hypoxia (C, from top to bottom).
TUNEL-positive nuclei are visualized as brown, with hematoxylin
staining used for counting total nuclei. Original magnification
x40.
checked every 30 min and titrated to 7.4 with 1M NaOH.
The total amount of base, equivalent to H+ release by the
heart, was assumed as an index of myocardial energy
expenditure (Figure 5), which was more marked for H
than LFI.
Discussion
No single model represents perfectly the cell death
signalling properties in adult ventricular myocytes [23].
Transformed cell lines are defective at one or more con-
trol points. Actively proliferating myocytes from embry-
onic sources are more vulnerable than non-cycling cells.
Primary cultures of neonatal and adult rat ventricular
myocytes lack contractile activity and cell-matrix com-
munication. Thus, establishing a model of apoptosis in
isolated organs is important because it represents a com-
promise between the simplicity of cultured cells and the
complexity of in vivo organs. Also, the metabolic inter-
relationships are intact, and pathophysiological stimuli
are applied independently of the neuro-hormonal sys-
tem. Finally, the control of dynamic and metabolic vari-
ables and the access to biochemical, physiological and
morphological techniques are optimal.
Lack of lymphocytes in the perfusion media pre-
vents phagocytosis of apoptotic cells and suppresses in-
flammatory responses. The prolonged permanence of
apoptotic cells might explain in part their large number.
Lack of red cells decreases total O
2
 supply, thereby po-
tentially inducing hypoxia. However, high PO
2
 and coro-
nary flow led O
2
 supply in controls to compare well with
9-10 µmoles/min/g reported for normally perfused hearts
[24]. Although not fully reflecting performance, heart
rate, a good index of myocardial viability, fell markedly
in association with O
2
 supply reduction.
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Fig. 4. Time-course of the
ratio (number of TUNEL-po-
sitive) / (number of TUNEL-
positive + number of hema-
toxylin-stained nuclei) in
hearts exposed to control con-
ditions, low-flow ischemia,
hypoxia, and global no-flow
ischemia followed by reper-
fusion (no medium recirculat-
ion). This ratio increased
almost linearly with time in
heart exposed to either low-
flow ischemia or hypoxia. In
contrast, it remained essen-
tially constant in control
hearts. Hearts exposed to
ischemia-reperfusion display-
ed higher ratio that hearts
exposed to low-flow ischemia
or hypoxia (n=2-4/point, the
bar represents S.D.).
The heart rate fall was more pronounced in the
recirculating than non-recirculating experiments. This
might be due either to glucose depletion or to lactate
accumulation in the medium. The maximal glucose uti-
lization in anoxic hearts (15-20 µmoles/g
dw
•min, or 1.95-
2.60 µmoles/g
ww
•min [25]) corresponds to 0.7 millimoles
uptake during a 6h perfusion (average heart weight 0.95
g). The glucose concentration in the recirculating me-
dium (total volume=800 mL) would therefore decrease
from 11 to 10.1 mM, which is irrelevant when compared
with the K
M
 of hexokinase for glucose (<0.1 mM). In
contrast, lactate concentration would increase to about 2
mM, and extracellular lactate is known to depress car-
diac function [26].
DNA fragments visualization, although a late event
not always occurring in the presence of apoptosis [27],
is nevertheless a hallmark of apoptosis. The TUNEL tech-
nique has been criticized for lack of standardization and
uncritical use and interpretation of data [28]. In addi-
tion, TUNEL-positivity often reflects a range of cellular
conditions wider than apoptosis only [29]. Nevertheless,
this technique is one of the most used to monitor apoptosis
Fig. 5. Ratio (number of
TUNEL-positive) / (number
of TUNEL-positive + number
of hematoxylin-stained nu-
clei) in, from left to right,
control hearts, and hearts
exposed to either low-flow
ischemia or hypoxia in the
recirculating and non-
recirculating mode. The bar
represents the S.D. (n=2-4/
group).
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in the myocardium. As the only variable is heart expo-
sure to LFI or H of varying duration, the apoptotic index
is intended relative to the effects exerted by the stresses
rather than the true expression of apoptotic cells number
[30]. Webster et al showed that H triggers apoptosis only
when combined with acidosis [14], but in the present
study with perfusion medium pH maintained constant
by titration, the degree of apoptosis did not change be-
tween LFI and H. Thus, acidosis was not needed for
apoptosis in this model.
After excluding studies with cultured cells, most
investigations into the effects of ischemia on apoptosis
concerned hearts exposed to global no-flow ischemia.
Yet, as ischemia reflects a situation where the energy
supply does not meet the demand [31], the most com-
mon condition related to ischemia involves restricted,
rather than abolished, coronary flow.
Comparing the derangement caused by LFI and H
helps addressing the mechanisms underlying apoptosis
in myocardial tissue. Despite matched O2 supply, heart
rate and H+ release were higher in H than LFI hearts.
This is consistent with previous observations indicating
myocardial down-regulation during LFI but not during
H, perhaps for the low coronary flow that decreases the
washout of membrane-diffusible factors, including lac-
tate, which depresses cardiac function [32]. Myocardial
down-regulation during LFI implies preservation of high-
energy phosphates [33], improved recovery [34] and
greater tolerance to sustained O2 supply reduction [35].
Despite such critical differences, the degree of apoptosis
was similar in LFI and H. The degree of apoptosis is
therefore apparently independent of the metabolic altera-
tion extent, and is triggered by non-diffusible factors
belonging to common paths in LFI and H. One of these
is tissue hypoxia, which may represent an important first
messenger of apoptosis that acts independently of the
oxidative stress originated from the reperfusion of
ischemic tissue.
Conclusion
The Langendorff-perfused heart is a suitable model
to study apoptosis and to test various hypotheses on
apoptosis insurgence during or after ischemia or hypoxia.
Hearts exposed to 1-h ischemia plus reperfusion display
a relevant degree of apoptosis, in agreement with sev-
eral reports. But low-flow ischemia and hypoxia with-
out reperfusion also stimulate apoptosis, although to a
lesser extent. As apoptosis was independent of medium
recirculation, and LFI and H were applied at the same
O2 supply, yet with different coronary flows, the short-
ened O2 supply, rather than the bioenergetic derangement
or the oxidative stress, appears a key trigger of apoptosis.
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